Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality

Journal of the American College of Cardiology

Volumn 57, Issue 5, 2011, Pages 556-562

  Van Rees, Johannes B ^a   Borleffs, C Jan Willem ^a   De Bie, Mihály K ^a   Stijnen, Theo ^a   Van Erven, Lieselot ^a   Bax, Jeroen J ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

implantable cardioverter defibrillator; inappropriate shock; mortality; sudden death

Indexed keywords

ADULT; AGED; ARTICLE; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INAPPROPRIATE SHOCK; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SHOCK; SURVIVAL;

AGED; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 79251577161     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.059     Document Type: Article

References (42)

1. R.J. Myerburg, K.M. Kessler, and A. Castellanos Sudden cardiac death: epidemiology, transient risk, and intervention assessment Ann Intern Med 119 1993 1187 1197
2. H.V. Huikuri, A. Castellanos, and R.J. Myerburg Sudden death due to cardiac arrhythmias N Engl J Med 345 2001 1473 1482
3. M. Josephson, and H.J. Wellens Implantable defibrillators and sudden cardiac death Circulation 109 2004 2685 2691
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
5. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
6. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
7. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
8. A.J. Moss, W.J. Hall, and D.S. Cannom Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1996 1933 1940
9. A. Kadish, A. Dyer, and J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
10. D.B. Mark, K.J. Anstrom, and J.L. Sun Quality of life with defibrillator therapy or amiodarone in heart failure N Engl J Med 359 2008 999 1008
11. L.A. Prudente Phantom shock in a patient with an implantable cardioverter defibrillator: case report Am J Crit Care 12 2003 144 146
12. E.B. Schron, D.V. Exner, and Q. Yao Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks Circulation 105 2002 589 594
13. D. Vollmann, L. Luthje, S. Vonhof, and C. Unterberg Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator Heart Rhythm 2 2005 307 309
14. J.E. Poole, G.W. Johnson, and A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
15. J.P. Daubert, W. Zareba, and D.S. Cannom Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
16. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
17. G. Gregoratos, J. Abrams, and A.E. Epstein ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) J Am Coll Cardiol 40 2002 1703 1719
18. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines Death) J Am Coll Cardiol 48 2006 e247 e346
19. S.L. Higgins, R.S. Lee, and R.L. Kramer Stability: an ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia J Cardiovasc Electrophysiol 6 1995 1081 1088
20. V. Kuhlkamp, V. Dornberger, C. Mewis, R. Suchalla, R.F. Bosch, and L. Seipel Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing J Cardiovasc Electrophysiol 10 1999 905 915
21. H. Burri, H. Sunthorn, D. Shah, and R. Lerch Optimization of device programming for cardiac resynchronization therapy Pacing Clin Electrophysiol 29 2006 1416 1425
22. I. Goldenberg, A.K. Vyas, and W.J. Hall Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
23. A.S. Levey, J. Coresh, and E. Balk National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
24. J.J. Germano, M. Reynolds, V. Essebag, and M.E. Josephson Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 97 2006 1255 1261
25. R.C. Klein, M.H. Raitt, and B.L. Wilkoff Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial J Cardiovasc Electrophysiol 14 2003 940 948
26. S.P. Bhavnani, C.I. Coleman, and C.M. White Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy Europace 10 2008 854 859
27. H. Hreybe, R. Ezzeddine, and W. Barrington Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks Am J Cardiol 97 2006 544 546
28. K. Nanthakumar, P. Dorian, and M. Paquette Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 8 2003 215 220
29. D. Soundarraj, R.K. Thakur, J.C. Gardiner, A. Khasnis, and K. Jongnarangsin Inappropriate ICD therapy: does device configuration make a difference Pacing Clin Electrophysiol 29 2006 810 815
30. D.A. Theuns, A.P. Klootwijk, M.L. Simoons, and L.J. Jordaens Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy Am J Cardiol 95 2005 271 274
31. A. Woo, D. Monakier, and L. Harris Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy Heart 93 2007 1044 1045
32. T. Kleemann, T. Becker, and K. Doenges Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years Circulation 115 2007 2474 2480
33. J.A. Ezekowitz, P.W. Armstrong, and F.A. McAlister Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials Ann Intern Med 138 2003 445 452
34. D.A. Theuns, A.P. Klootwijk, D.M. Goedhart, and L.J. Jordaens Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms J Am Coll Cardiol 44 2004 2362 2367
35. I. Deisenhofer, C. Kolb, and G. Ndrepepa Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study J Cardiovasc Electrophysiol 12 2001 134 142
36. A. Al-Ahmad, P.J. Wang, M.K. Homoud, N.A. Estes III, and M.S. Link Frequent ICD shocks due to double sensing in patients with bi-ventricular implantable cardioverter defibrillators J Interv Card Electrophysiol 9 2003 377 381
37. P.A. Friedman, R.L. McClelland, and W.R. Bamlet Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study Circulation 113 2006 2871 2879
38. T. Schluter, H. Baum, A. Plewan, and D. Neumeier Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage Clin Chem 47 2001 459 463
39. A. Sherwood, J.A. Blumenthal, and R. Trivedi Relationship of depression to death or hospitalization in patients with heart failure Arch Intern Med 167 2007 367 373
40. C.J. Borleffs, J.B. van Rees, and G.H. van Welsenes Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 2010 879 885
41. J.J. Allan, R.D. Feld, and A.A. Russell Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion J Am Coll Cardiol 30 1997 1052 1056
42. T.M. Hurst, M. Hinrichs, C. Breidenbach, N. Katz, and B. Waldecker Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators J Am Coll Cardiol 34 1999 402 408